The activity of the p53 gene product is regulated by a plethora of posttranslational modifications. An open question is whether such posttranslational changes act redundantly or dependently upon one another. We show that a functional interference between specific acetylated and phosphorylated residues of p53 influences cell fate. Acetylation of lysine 320 (K320) prevents phosphorylation of crucial serines in the NH2-terminal region of p53; only allows activation of genes containing high-affinity p53 binding sites, such as p21/WAF; and promotes cell survival after DNA damage. In contrast, acetylation of K373 leads to hyperphosphorylation of p53 NH2-terminal residues and enhances the interaction with promoters for which p53 possesses low DNA binding affinity, such as those contained in proapoptotic genes, leading to cell death. Further, acetylation of each of these two lysine clusters differentially regulates the interaction of p53 with coactivators and corepressors and produces distinct gene-expression profiles. By analogy with the “histone code” hypothesis, we propose that the multiple biological activities of p53 are orchestrated and deciphered by different “p53 cassettes,” each containing combination patterns of posttranslational modifications and protein–protein interactions.
Skip Nav Destination
Article navigation
22 May 2006
Article|
May 22 2006
Distinct p53 acetylation cassettes differentially influence gene-expression patterns and cell fate
Chad D. Knights,
Chad D. Knights
1Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20057
Search for other works by this author on:
Jason Catania,
Jason Catania
1Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20057
Search for other works by this author on:
Simone Di Giovanni,
Simone Di Giovanni
1Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20057
Search for other works by this author on:
Selen Muratoglu,
Selen Muratoglu
2Department of Pathology, Center for Vascular and Inflammatory Disease, University of Maryland, Baltimore, MD 21201
Search for other works by this author on:
Ricardo Perez,
Ricardo Perez
1Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20057
Search for other works by this author on:
Amber Swartzbeck,
Amber Swartzbeck
1Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20057
Search for other works by this author on:
Andrew A. Quong,
Andrew A. Quong
3Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107
Search for other works by this author on:
Xiaojing Zhang,
Xiaojing Zhang
4Department of Pharmacology, Roswell Park Cancer Institute, Buffalo, NY 14203
Search for other works by this author on:
Terry Beerman,
Terry Beerman
4Department of Pharmacology, Roswell Park Cancer Institute, Buffalo, NY 14203
Search for other works by this author on:
Richard G. Pestell,
Richard G. Pestell
3Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107
Search for other works by this author on:
Maria Laura Avantaggiati
Maria Laura Avantaggiati
1Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20057
Search for other works by this author on:
Chad D. Knights
1Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20057
Jason Catania
1Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20057
Simone Di Giovanni
1Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20057
Selen Muratoglu
2Department of Pathology, Center for Vascular and Inflammatory Disease, University of Maryland, Baltimore, MD 21201
Ricardo Perez
1Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20057
Amber Swartzbeck
1Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20057
Andrew A. Quong
3Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107
Xiaojing Zhang
4Department of Pharmacology, Roswell Park Cancer Institute, Buffalo, NY 14203
Terry Beerman
4Department of Pharmacology, Roswell Park Cancer Institute, Buffalo, NY 14203
Richard G. Pestell
3Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107
Maria Laura Avantaggiati
1Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20057
Correspondence to Maria Laura Avantaggiati: [email protected]
C.D. Knights and J. Catania contributed equally to this paper.
Abbreviations used in this paper: ChIP, chromatin immunoprecipitation; CPI, cyclopropylpyrroloindole; EMSA, electrophoretic mobility shift assay; PCAF, p300/CBP-associated factor; WT, wild-type.
Received:
December 12 2005
Accepted:
April 18 2006
Online ISSN: 1540-8140
Print ISSN: 0021-9525
The Rockefeller University Press
2006
J Cell Biol (2006) 173 (4): 533–544.
Article history
Received:
December 12 2005
Accepted:
April 18 2006
Connected Content
Related
Acetylate to kill or save
Citation
Chad D. Knights, Jason Catania, Simone Di Giovanni, Selen Muratoglu, Ricardo Perez, Amber Swartzbeck, Andrew A. Quong, Xiaojing Zhang, Terry Beerman, Richard G. Pestell, Maria Laura Avantaggiati; Distinct p53 acetylation cassettes differentially influence gene-expression patterns and cell fate . J Cell Biol 22 May 2006; 173 (4): 533–544. doi: https://doi.org/10.1083/jcb.200512059
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSee also
Email alerts
Advertisement
Advertisement